Development of neutralizing antibodies in individuals who have been exposed to the human immunodeficiency virus (HIV/HTLV-III/LAV).
Also Known As:
AIDS Seroconversions; AIDS Seropositivities; Anti HIV Positivity; Anti-HIV Positivities; Antibody Positivities, HIV; Antibody Positivity, HIV; HIV Antibody Positivities; HIV Seroconversions; HIV Seropositivities; HTLV III Seroconversion; HTLV III Seropositivity; HTLV-III Seroconversions; HTLV-III Seropositivities; Positivities, Anti-HIV; Positivities, HIV Antibody; Positivity, Anti-HIV; Positivity, HIV Antibody; Seroconversion, AIDS; Seroconversion, HIV; Seroconversion, HTLV-III; Seroconversions, AIDS; Seroconversions, HIV; Seroconversions, HTLV-III; Seropositivities, AIDS; Seropositivities, HIV; Seropositivities, HTLV-III; Seropositivity, AIDS; Seropositivity, HIV; Seropositivity, HTLV-III; AIDS Seroconversion; AIDS Seropositivity; Anti-HIV Positivity; HIV Antibody Positivity; HIV Seroconversion; HTLV-III Seroconversion; HTLV-III Seropositivity